The nation's top pharmaceutical trade group is taking a legal swing at Rhode Island's new drug-pricing law.

In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...

Tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total community benefits in 2022. According to ...

Rather than using their federal 340B drug discount savings to lower costs for patients, many hospitals reinvest their profits into acquiring independent clinics.

The 340B Drug Pricing Program was created to benefit low-income and uninsured Americans. Over time, it has morphed into a federal subsidy for hospitals in affluent areas at the expense ...

Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain ...

North Dakota is being sued by a second pharmaceutical company over legislation passed during the 2025 session that expands access to drugs discounted by the federal 340B program. Drug maker ...

Experts discuss the implications of Most Favored Nation pricing on U.S. drug costs, innovation and patient access in the ...

Cambridge Health Alliance is “deeply concerned” about proposed changes to a prescription drug discount program that has ...

Show airing Sept. 27 on Fox Business spotlights businesses that simplify property management, provide data management and AI services, fight tax cases and unlock federal health care funds. NEW YORK ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

Algen Biotechnologies partners with AstraZeneca in a $555 million deal to advance AI-driven CRISPR drug discovery and novel ...